Beta
Back to NVO.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
net-income-chart

NVO Net Income

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for NVO's net income in Q4'25 shows $26.89B USD, reflecting a slight decline from the previous quarter's $20.01B USD but remaining above the annual average. This figure represents a year-over-year decrease of -4.74%, indicating moderated growth compared to earlier periods in 2025. Over the period from Q1'23 to Q4'25, net income has exhibited an overall upward trend, rising from $19.81B USD to a peak of $29.03B USD in Q1'25, with notable volatility including a dip to $20.05B USD in Q2'24 and a sharp YoY contraction of -26.72% in Q3'25. Year-over-year growth started strong at 39.44% in Q1'23, peaking at 61.59% in Q4'23, before decelerating and turning negative in late 2025, suggesting potential headwinds in profitability despite the long-term expansion driven by the pharmaceutical sector's demand. The bar chart visualization highlights quarterly fluctuations, while the overlaid YoY line underscores shifting momentum.